经鼻间歇正压通气用于新生儿呼吸窘迫综合征的临床价值  

Clinical Value of Transnasal Intermittent Positive Pressure Ventilation in Neonatal Respiratory Distress Syndrome

作　　者：高维凤 李金嫦 GAO Weifeng;LI Jinchang(Yunfu Maternal and Child Health Hospital.Yunfu 527300,China)

机构地区：[1]云浮市妇幼保健院,广东云浮527300

出　　处：《中国医药指南》2021年第13期67-68,共2页Guide of China Medicine

摘　　要：目的探究在新生儿呼吸窘迫综合征治疗中应用经鼻间歇正压通气所取得的应用价值。方法选取2019年9月至2020年12月50例呼吸窘迫综合征新生儿,按照随机分组法,每组25例。对照组经鼻持续正压通气治疗,观察组经鼻间歇正压通气治疗。比较两组治疗前后pH值及PaO2指标,并发症发生率及临床治疗效果。结果治疗前两组pH值及PaO2指标对比无差异(P>0.05);治疗后12 h及24 h观察组pH值及PaO2指标高于对照组,并发症发生率低于对照组,临床治疗有效率高于对照组(P<0.05)。结论在新生儿呼吸窘迫综合征治疗中应用经鼻间歇正压通气治疗法展现出了较高的临床应用价值。Objective To explore the value of transnasal intermittent positive pressure ventilation in the treatment of neonatal respiratory distress syndrome.Methods Selected 50 newborns with respiratory distress syndrome from September 2019 to December 2020,and included 25 cases of each group by randomization.The control group underwent continuous transnasal positive pressure ventilation treatment,and the compared group underwent intermittent transnasal positive pressure ventilation treatment.pH value and PaO2 index,complication rate and clinical treatment effect were compared.Results There was no difference between pH and PaO2 indicators in the first two groups(P>0.05);pH and PaO2 in the 12 hours and 24 hours observation groups were higher than in the control group,the complication rate was lower than in the control group,and higher clinical efficiency than in the control group(P<0.05).Conclusion The application of transnasal intermittent positive pressure ventilation in the treatment of neonatal respiratory distress syndrome shows high clinical value.

关 键 词：呼吸窘迫综合征 经鼻间歇正压通气 经鼻持续正压通气 并发症 治疗效果 

分 类 号：R563.8[医药卫生—呼吸系统]